# Fructose-induced Hepatic De Novo Lipogenesis in Adolescents With Obesity

> **NCT03567837** · NA · TERMINATED · sponsor: **The Rogosin Institute** · enrollment: 12 (actual)

## Conditions studied

- Adolescent Obesity

## Interventions

- **OTHER:** Fructose + Glucose Beverage

## Key facts

- **NCT ID:** NCT03567837
- **Lead sponsor:** The Rogosin Institute
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2018-08-13
- **Primary completion:** 2019-06-04
- **Final completion:** 2019-06-04
- **Target enrollment:** 12 (ACTUAL)
- **Why stopped:** It was stopped due to the inability to recruit during the Covid epidemic.
- **Last updated:** 2024-03-15

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03567837

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03567837, "Fructose-induced Hepatic De Novo Lipogenesis in Adolescents With Obesity". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT03567837. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*
